Blankenbiller, Tricia
Mayo Clinic
Teva Pharmaceuticals (United States)
Citations 4
Efficacy of Two Dose Regimens of Subcutaneous Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (S32.005)
Silberstein, Stephen D., Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)
Silberstein, Stephen D., Yeung, Paul, Blankenbiller, Tricia , Ning, Xiaoping , Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Bigal, Marcelo E. , Goadsby, Peter J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093)
Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Silberstein, Stephen D., Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
Silberstein, Stephen D., Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Dodick, David W. , Goadsby, Peter J.
JAMA | May 17, 2018 | Volume: 319 | Issue: 19 | Pages: 1999